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Abstract
Since publication of our article (Ahmed and Sechi: Ann Clin Microbiol Antimicrob 2005, 4:1), we have
noticed several errors.
Correction
We lately discovered that due to an inadvertent and acci-
dental mistake, our review/update [1] needs some impor-
tant corrections; we profusely regret and offer our
sincerest apologies and correct the text as under.
Please be aware that throughout this article the citations
in round brackets refer to the reference list from the origi-
nal manuscript [1], and the citations in square brackets
refer to newly introduced citations that appear in the ref-
erence list at the end of this manuscript.
The following sentence should have been included at the
end of the original abstract.
"This review is written with a fair interest to reproduce,
through open access channel, a follow up and update
of our previous detailed discussions on the subject
(Carroll et al: Infect Genet Evol. 2004, 4:81–90)."
In 'The conundrum of strain diversity...' section, the first
three sentences should have read:
"Within the bacterial populations, genome content keeps
recasting due to selection pressures, as a result genomic
diversity increases; this facilitates adaptation of particular
strains to permissive hosts. H. pylori with its highly
diverse gene pool is therefore, a model for studying
genome plasticity in the context of colonization of indi-
vidual hosts (34)."
In the "Link with cancer: the oncogenic cagA protein"
section, the eighth sentence onwards should read as fol-
lows.
"The phosphorylated CagA (51, 52) binds to a SHP2
phosphatase which acts as an oncoprotein (64). The
phosphorylated CagA mediated derangement of SHP2
signaling is an important putative mechanism of H.
pylori induced gastric carcinogenesis (64, 65). Based
on type and abundance of tyrosine phosphorylation
motifs (TPM) (52), CagA is classified as East Asian and
Western types (64)'. East Asian type of CagA is
regarded as a risk factor possibly due to its high biolog-
ical activity (63, 64) and therefore, high incidence of
gastric cancer in East Asian countries might be the
reflection of this. One puzzling attribute of H. pylori is
the differential outcome of infection and severity of
inflammation in different populations of the world
(63). Possible explanation for this might originate
from the analysis of genetic (polymorphism of human
genes encoding receptors for H. pylori adhesins), envi-
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ronmental (diet) and social factors (transmission
dynamics). Among these, diversity of cagA in H. pylori
strains might be involved in determination of the type
and severity of disease. The East-Asian and Western
forms of CagA possess structurally distinct tyrosine
phosphorylation/SHP2-binding sites – EPIYA-D and
EPIYA-C, respectively (64). Interestingly, the severity
of inflammation, activity of gastritis, and the extent of
atrophy were significantly higher in patients with gas-
tritis who were infected with the East-Asian type cagA-
positive strains as compared to patients who were
infected either with cagA-negative or Western type
cagA-positive strains (65). Gastric cancer mortality in
Japan could be associated with large prevalence of East
Asian type CagA containing isolates (65), thus
explaining that patients colonized with such isolates
might be at the highest risk of developing gastric can-
cer as compared to those who are colonized with
Western type CagA containing H. pylori.
Among Western-CagA harboring strains, the numbers
of EPIYA-C sites directly correlate with levels of tyro-
sine phosphorylation, SHP2-binding and morpholog-
ical types of epithelial cells (hummingbird effect)
(64). It has been described that the number of TPM of
EPIYA-C (western) type determine the severity of
atrophic gastritis and its outcome (cancer) in the cases
of infection caused by strains that harbor Western type
CagA (66)."
In the section "The number-2 virulence determinant:
vacuolating cytotoxin (VacA) of H. pylori" sentences five-
eight should have cited references (20, 2, 22).
"VacA protein, a secreted 95 kD peptide, varies in the
signal sequence (alleles s1a, s1b, s1c, s2) and/or its
middle region (alleles m1, m2) between different H.
pylori strains (20, 21, 22). The different combinations
of s and m regions determine the production of cyto-
toxic activity. Strains with the genotype s1 m1 produce
high levels of vacuolating cytotoxin in vitro (20, 21,
22). Strains with the genotype s2 failed to produce
detectable toxin (20)."
Sentence 13 should have cited new references.
"Among other functions, VacA is suggested to inhibit
invariant chain (Ii)-dependent pathway of antigen
presentation mediated by the MHC class II, and, to
possibly induce apoptosis of epithelial cells [2,3]."
Sentence 14 to the end, should have read as follows.
"Apart from its well-known and widely discussed cyto-
toxic role (20, 21, 22), VacA has been shown to cause
apoptosis [3] and inhibition of lymphocyte prolifera-
tion and thereby promotes a possible condition of
local immunosuppression [4]."
In section "Plasticity region cluster" sentence five should
not have referenced Figure 1.
"This type IV cluster is comprised of 7 genes, homolo-
gous to the vir B operon of A. tumifaciens carried in a
16.3 kb genomic fragment called tfs3."
In section "Do we need to eradicate H. pylori from this
earth?" within the second paragraph, the second and
third sentences should have cited new references [5,6] and
read:
"In addition, the incidence of H. pylori-negative, non-
NSAID peptic ulcer disease (PUD) (idiopathic PUD) is
reported to increase with time. Also, it appears that H.
pylori-positive ulcers are not necessarily the H. pylori-
induced ulcers because there are two possible out-
comes of the H. pylori induced pathology, first the
existence of H. pylori-positive non-recurring ulcer and
secondly, recurring ulcer after cure of H. pylori infec-
tion [5,6]."
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